DLB Dolby Laboratories (DLB) Insider Trading, Ownership & Congress Trades
Services · Patent owners & lessors · CIK 0001308547
Form 144 · 6
Insider buyers, 180 days
0
House members buying, 1 year
0
STOCK Act, US House only, disclosed up to 45 days after the trade
Funds added, last quarter
198
13F, latest reported quarter
Conversions, 180 days
7
Codes C/M, not in net · $2.1M priced
What the filings say about DLB
Insiders, 180 days
-$4.4M net sold
5 sellers · 16% of sales under a 10b5-1 plan
Congress, 1 year
No trades
Last one: sale, 2025-09-25
Planned sales (Form 144), 90 days
$1.7M
6 notices
Dolby Laboratories insider trades (Form 4)
Form 4 buys and sells (codes P and S). Grants, option exercises
and conversions excluded.
Over the last 180 days, Dolby Laboratories, Inc. insiders sold a net $4.4M of stock across 190 Form 4 purchases and sales, with no insider buying. Source: SEC Form 4 filings, as of 2026-10-27.
Insider
Filed
Shares
Value
Since filing
Context
- 35 earlier Form 4 trades (code P or S) here by this insider (35 sales), the last on Sep 1, 2026.
- The trade is 4.1% of the 167,639 shares held after it.
- No other insider sold within 30 days.
- 198 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: SVP, Entertainment Couling John D sold about $401.1K of DLB under a 10b5-1 plan on Oct 1, 2026; 198 funds added in the latest 13F quarter.Context
- 35 earlier Form 4 trades (code P or S) here by this insider (35 sales), the last on Sep 1, 2026.
- The trade is 0.5% of the 166,803 shares held after it.
- No other insider sold within 30 days.
- 198 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: SVP, Entertainment Couling John D sold about $49.6K of DLB under a 10b5-1 plan on Oct 1, 2026; 198 funds added in the latest 13F quarter.Context
- 34 earlier Form 4 trades (code P or S) here by this insider (34 sales), the last on Aug 3, 2026.
- The trade is 6.5% of the 118,727 shares held after it.
- 2 other insiders sold within 30 days.
- 198 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: SVP, Entertainment Couling John D sold about $468.0K of DLB under a 10b5-1 plan on Sep 1, 2026; 2 other insiders sold within 30 days and 198 funds added in the latest 13F quarter.Context
- 9 earlier Form 4 trades (code P or S) here by this insider (9 sales), the last on Aug 10, 2026.
- The trade is 3.4% of the 34,453 shares held after it.
- 2 other insiders sold within 30 days.
- 198 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: VP, CAO and Corp. Controller Nicholson Ryan sold about $77.2K of DLB on Aug 25, 2026; 2 other insiders sold within 30 days and 198 funds added in the latest 13F quarter.Context
- 4 earlier Form 4 trades (code P or S) here by this insider (4 sales), the last on May 15, 2026.
- The trade is 4.1% of the 73,274 shares held after it.
- 2 other insiders sold within 30 days.
- 198 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: SVP, Advanced Technology Group Revankar Shriram sold about $188.1K of DLB on Aug 14, 2026; 2 other insiders sold within 30 days and 198 funds added in the latest 13F quarter.190 transactions on record
Since filing: total return from the first close after the filing to the latest close, dividend-adjusted. Not a forecast.
Context lines are counts over the filings above and returns from our own price history, never a price level. Not investment advice.
Seven facts, ranked against the sector ·
Rank is not a forecast
Insiders
net -$4.4M over 180 days
-$1.7M over 90 days
below 74% of Services
Congress
no House purchase disclosed in the last 12 months
Funds
198 funds bought in last quarter
more than 72% of Services
Revenue
+5.9% year over year
more than 52% of Services
Margin
18.9% net margin
more than 87% of Services
Buybacks
$200.0M repurchased, FY to 2026-06-26
more than 71% of Services
Short interest
10.1% of the float short (float per yahoo 2026-10-26) · 5.9 days to cover · settled 2026-09-30
What changed in the last 30 days
Oct 5SVP, Entertainment Couling John D sold $450.7K under a 10b5-1 plan (Oct 1)
Why it matters
A 10b5-1 plan schedules trades months ahead, so this says little about what the insider thinks today.
Oct 1Officer JOHN COULING filed to sell $450.7K by Oct 1 (Form 144)
Why it matters
A Form 144 is a notice of intent to sell; the sale may not happen, and it says nothing about the price.
Watch DLB
A free account keeps a watchlist and can send one email a day when insiders, funds or Congress file on the names in it. No password and no card.
The year, with the filings on it
Total return over 12 months. Each marker is a filing; hover or tap one for the detail.
-4.3%12M
Insider sellForm 144 (planned sale)
Indexed to 100, dividend-adjusted, not a price chart.
When a name files heavily, the largest trades are drawn first.
Who owns DLB: institutional holders (13F)
13F holdings, latest reported quarter
6,676,885 sh
$351.1M
4,950,702 sh
$260.3M
4,817,216 sh
$253.3M
4,601,750 sh
$242.0M
2,721,876 sh
$143.1M
Congress trades in DLB
STOCK Act disclosures, US House only, filed up to 45 days after the trade
Sold 2025-09-25 · disclosed 27 days later
$1,001 - $15,000
Bought 2025-09-11 · disclosed 41 days later
$1,001 - $15,000
Sold 2025-08-04 · disclosed 39 days later
$1,001 - $15,000
Bought 2025-06-24 · disclosed 50 days later
$1,001 - $15,000
Activist and 5% holders (13D/13G)
No 5%+ ownership filings
Nobody has filed for crossing 5%. That is a fact, not missing data.
DLB planned insider sales (Form 144)
Notice of intent to sell, filed before any sale
JOHN COULING
Filed 2026-10-01
$450.7K
JOHN COULING
Filed 2026-09-01
$468.0K
RYAN H NICHOLSON
Filed 2026-08-25
$77.2K
SHRIRAM REVANKAR
Filed 2026-08-14
$188.1K
RYAN H NICHOLSON
Filed 2026-08-10
$83.6K
DLB mutual fund holders (N-PORT)
Funds ranked by the share of their own portfolio in this stock (N-PORT).
GMO Small Cap Quality Fund
$17.0M position · as of 2026-05-31
2.4%
Cambiar SMID Fund
$900.7K position · as of 2026-07-31
2.3%
ProShares S&P Technology Dividend Aristocrats ETF
$6.0M position · as of 2026-05-31
2.1%
The Disciplined Growth Investors Equity Fund
$2.9M position · as of 2026-07-31
1.6%
ALPS | OShares U.S. Small-Cap Quality Dividend ETF
$13.7M position · as of 2026-05-31
1.6%
Hunter Small Cap Value Fund
$1.0M position · as of 2026-07-31
1.6%
SEC N-PORT, monthly, about 60 days late · funds ≥ $10M ·
% is the share of the fund's own portfolio
Executive pay vs shareholder return · Kevin Yeaman
CEO pay, headline and as actually paid, against the company's
return and its chosen peers' (DEF 14A).
FY
CEO total
Actually paid
Other execs, avg
TSR
Peer TSR
2025
$10.2M
$8.7M
$3.9M
+19%
+94%
2024
$9.7M
$5.9M
$3.6M
+22%
+83%
2023
$9.5M
$13.7M
$3.5M
+26%
+44%
2022
$9.4M
$27.5K
$3.6M
+2%
+25%
2021
$9.6M
$23.6M
$3.4M
+44%
+50%
Tagged by the company under SEC Item 402(v). Returns are
cumulative from the start of the disclosure period. Green where the company beat its own peer group.
Live price
Daily candles from TradingView, under their licence. No filings marked.
Why this name is on the desk
Insiders have filed to sell, before selling.
The record shows a net $4.4M sold by insiders over 180 days, 198 funds added last quarter, $1.7M in planned Form 144 sales. Each figure is a federal filing, dated the day it went public.
DLB financials
Revenue growth
+5.9%
XBRL, annual
Net margin
18.9%
Ratios from the company's XBRL filings, latest filings
Revenue, TTM
$1.4B
four quarters, 2025-06-28 to 2026-06-26
Revenue, TTM DLB
| FY Sep 2025 | $1.3B |
| FY Sep 2024 | $1.3B |
| FY Sep 2023 | $1.3B |
| FY Sep 2022 | $1.3B |
| FY Sep 2021 | $1.3B |
| Jun 2026 | $305.0M |
| Mar 2026 | $395.6M |
| Dec 2025 | $346.7M |
| Sep 2025 | $307.0M |
| Jun 2025 | $315.5M |
| Mar 2025 | $369.6M |
| Dec 2024 | $357.0M |
| Sep 2024 | $304.8M |
At each fiscal year end
Single quarter
Net margin, TTM
+16.7%
net income over revenue, 2025-06-28 to 2026-06-26
Net margin, TTM DLB
| FY Sep 2025 | +18.9% |
| FY Sep 2024 | +20.6% |
| FY Sep 2023 | +15.4% |
| FY Sep 2022 | +14.7% |
| FY Sep 2021 | +24.2% |
| Jun 2026 | +9.4% |
| Mar 2026 | +24.0% |
| Dec 2025 | +15.4% |
| Sep 2025 | +16.1% |
| Jun 2025 | +14.6% |
| Mar 2025 | +24.8% |
| Dec 2024 | +19.0% |
| Sep 2024 | +19.2% |
At each fiscal year end
Single quarter
Free cash flow, TTM
$392.7M
operating cash flow minus capex, 2025-06-28 to 2026-06-26
Free cash flow, TTM DLB
| FY Sep 2025 | $435.9M |
| FY Sep 2024 | $297.2M |
| FY Sep 2023 | $336.7M |
| FY Sep 2022 | $270.6M |
| FY Sep 2021 | $393.3M |
| Jun 2026 | $152.5M |
| Mar 2026 | $83.4M |
| Dec 2025 | $50.2M |
| Sep 2025 | $106.6M |
| Jun 2025 | $61.3M |
| Mar 2025 | $168.0M |
| Dec 2024 | $100.0M |
| Sep 2024 | $108.8M |
At each fiscal year end
Single quarter
Debt to equity
n/a
no debt line filed
Debt to equity DLB
| FY Sep 2025 | n/a |
| FY Sep 2024 | n/a |
| FY Sep 2023 | n/a |
| FY Sep 2022 | n/a |
| FY Sep 2021 | n/a |
| Jun 2026 | n/a |
| Mar 2026 | n/a |
| Dec 2025 | n/a |
| Sep 2025 | n/a |
| Jun 2025 | n/a |
| Mar 2025 | n/a |
| Dec 2024 | n/a |
| Sep 2024 | n/a |
At each fiscal year end
Trailing four quarters at each quarter end
Cash flow to debt
n/a
no debt line filed
Cash flow to debt DLB
| FY Sep 2025 | n/a |
| FY Sep 2024 | n/a |
| FY Sep 2023 | n/a |
| FY Sep 2022 | n/a |
| FY Sep 2021 | n/a |
| Jun 2026 | n/a |
| Mar 2026 | n/a |
| Dec 2025 | n/a |
| Sep 2025 | n/a |
| Jun 2025 | n/a |
| Mar 2025 | n/a |
| Dec 2024 | n/a |
| Sep 2024 | n/a |
At each fiscal year end
Trailing four quarters at each quarter end
Return on equity
+8.7%
TTM net income over average of 2025-06-27 and 2026-06-26
Return on equity DLB
| FY Sep 2025 | +10.0% |
| FY Sep 2024 | +10.8% |
| FY Sep 2023 | +8.7% |
| FY Sep 2022 | +7.6% |
| FY Sep 2021 | +12.3% |
| Jun 2026 | +8.7% |
| Mar 2026 | +9.4% |
| Dec 2025 | +9.4% |
| Sep 2025 | +10.0% |
| Jun 2025 | +10.5% |
| Mar 2025 | +10.3% |
| Dec 2024 | +10.8% |
| Sep 2024 | +10.8% |
At each fiscal year end
Trailing four quarters at each quarter end
Return on assets
+7.1%
TTM net income over average of 2025-06-27 and 2026-06-26
Return on assets DLB
| FY Sep 2025 | +8.0% |
| FY Sep 2024 | +8.6% |
| FY Sep 2023 | +7.1% |
| FY Sep 2022 | +6.4% |
| FY Sep 2021 | +10.3% |
| Jun 2026 | +7.1% |
| Mar 2026 | +7.5% |
| Dec 2025 | +7.6% |
| Sep 2025 | +8.0% |
| Jun 2025 | +8.6% |
| Mar 2025 | +8.2% |
| Dec 2024 | +8.6% |
| Sep 2024 | +8.6% |
At each fiscal year end
Trailing four quarters at each quarter end
Return on invested capital
n/a
no debt line filed
Return on invested capital DLB
| FY Sep 2025 | n/a |
| FY Sep 2024 | n/a |
| FY Sep 2023 | n/a |
| FY Sep 2022 | n/a |
| FY Sep 2021 | n/a |
| Jun 2026 | n/a |
| Mar 2026 | n/a |
| Dec 2025 | n/a |
| Sep 2025 | n/a |
| Jun 2025 | n/a |
| Mar 2025 | n/a |
| Dec 2024 | n/a |
| Sep 2024 | n/a |
At each fiscal year end
Trailing four quarters at each quarter end
Return on capital employed
+8.6%
operating income (EBIT proxy) over average of 2025-06-27 and 2026-06-26 minus current liabilities
Return on capital employed DLB
| FY Sep 2025 | +9.7% |
| FY Sep 2024 | +9.8% |
| FY Sep 2023 | +8.7% |
| FY Sep 2022 | +7.9% |
| FY Sep 2021 | +12.7% |
| Jun 2026 | +8.6% |
| Mar 2026 | +9.1% |
| Dec 2025 | +9.0% |
| Sep 2025 | +9.7% |
| Jun 2025 | +10.4% |
| Mar 2025 | +10.1% |
| Dec 2024 | +10.3% |
| Sep 2024 | +9.8% |
At each fiscal year end
Trailing four quarters at each quarter end
P/E, trailing
26.74x
close 2026-10-23 over four quarters of diluted EPS, 2025-06-28 to 2026-06-26
P/E, trailing DLB
| FY Sep 2025 | 27.52x |
| FY Sep 2024 | 28.00x |
| FY Sep 2023 | 38.48x |
| FY Sep 2022 | 35.99x |
| FY Sep 2021 | 31.03x |
| Jun 2026 | 22.76x |
| Mar 2026 | 22.94x |
| Dec 2025 | 26.50x |
| Sep 2025 | 27.52x |
| Jun 2025 | 27.22x |
| Mar 2025 | 30.27x |
| Dec 2024 | 28.96x |
| Sep 2024 | 28.00x |
At each fiscal year end
Trailing four quarters at each quarter end
Enterprise value
n/a
no share count filed
Enterprise value DLB
| FY Sep 2025 | n/a |
| FY Sep 2024 | n/a |
| FY Sep 2023 | n/a |
| FY Sep 2022 | n/a |
| FY Sep 2021 | n/a |
| Jun 2026 | n/a |
| Mar 2026 | n/a |
| Dec 2025 | n/a |
| Sep 2025 | n/a |
| Jun 2025 | n/a |
| Mar 2025 | n/a |
| Dec 2024 | n/a |
| Sep 2024 | n/a |
At each fiscal year end
Trailing four quarters at each quarter end
FCF yield
n/a
no share count filed
FCF yield DLB
| FY Sep 2025 | n/a |
| FY Sep 2024 | n/a |
| FY Sep 2023 | n/a |
| FY Sep 2022 | n/a |
| FY Sep 2021 | n/a |
| Jun 2026 | n/a |
| Mar 2026 | n/a |
| Dec 2025 | n/a |
| Sep 2025 | n/a |
| Jun 2025 | n/a |
| Mar 2025 | n/a |
| Dec 2024 | n/a |
| Sep 2024 | n/a |
At each fiscal year end
Trailing four quarters at each quarter end
PEG, trailing
n/a
trailing EPS growth -14%, PEG needs growth
PEG, trailing DLB
| FY Sep 2025 | n/a |
| FY Sep 2024 | 0.90x |
| FY Sep 2023 | 2.79x |
| FY Sep 2022 | n/a |
| FY Sep 2021 | 0.96x |
| Jun 2026 | n/a |
| Mar 2026 | n/a |
| Dec 2025 | n/a |
| Sep 2025 | n/a |
| Jun 2025 | 1.12x |
| Mar 2025 | 0.87x |
| Dec 2024 | 0.72x |
| Sep 2024 | 0.90x |
At each fiscal year end
Trailing four quarters at each quarter end
Price as of 2026-10-23. Hover or tap a tile for its yearly and quarterly history.
Method
TTM is four consecutive fiscal quarters; Q4 is the year minus nine months when not filed. Returns use the average of opening and closing balances. EBIT is approximated by operating income. PEG uses trailing EPS growth.
Fundamentals
Annual figures from XBRL filings. Pick a past date to see them as known then.
| 2025-09 | 2024-09 | 2023-09 | 2022-09 | |
|---|---|---|---|---|
| Revenue | $1.3B | $1.3B | $1.3B | $1.3B |
| Gross profit | $1.2B | $1.1B | $1.1B | $1.1B |
| Operating income | $265.0M | $258.3M | $215.8M | $206.6M |
| Net income | $255.0M | $261.8M | $200.7M | $184.1M |
| EPS (diluted) | 2.62 | 2.69 | 2.05 | 1.81 |
| Operating cash flow | $472.2M | $327.3M | $367.1M | $318.6M |
| Cash | $701.9M | $482.0M | $745.4M | $620.1M |
| Buybacks | $125.0M | $160.0M | $149.3M | $530.5M |
| Dividends paid | $126.6M | $114.6M | $103.4M | $100.1M |
SEC XBRL, fiscal years, as known on 2026-10-27
DLB Stock Sonar score 5/7 axes
Find similar shapesCompareDLB ranks highest on profitability (63rd percentile) and institutional and government (46th), and lowest on insider conviction (14th), among Services peers.
5 of 7 axes scored. Each is a percentile against sector peers (all companies when the sector is thin); higher is better. An unscored axis is unmeasured, not low. How it is scored
DLB filings, in plain words
Are Dolby Laboratories insiders buying or selling DLB?
In the 180 days to 2026-10-27, Dolby Laboratories insiders were net sellers, a net $4.4M across purchases and sales reported on Form 4, by 5 sellers.
Have members of Congress traded DLB?
Yes, but not in the year to 2026-10-27; the latest on record is a sale by Lisa McClain dated 2025-09-25.
Are there planned insider sales of DLB?
Yes. 6 Form 144 notices of planned insider sales were filed in the 90 days to 2026-10-27, covering $1.7M of stock; the latest, by JOHN COULING, was filed 2026-10-01.
Read the full summary
In the 180 days to 2026-10-27, Dolby Laboratories insiders were net sellers of DLB, a net $4.4M across purchases and sales reported on Form 4 by 5 sellers. 16% of the 19 insider sales were made under a Rule 10b5-1 plan; the rest were not flagged as planned. Members of Congress have disclosed trades in DLB, none in the last year; the latest on record is a sale by Lisa McClain dated 2025-09-25. Insiders filed 6 Form 144 notices of intent to sell in the 90 days to 2026-10-27, covering $1.7M of stock. Each figure is counted from SEC and House filings as of 2026-10-27, dated the day the filing was made public.
Explore insider trading and ownership data
Every company we track, ranked by each kind of filing
